Researchers have discovered a new way that neurons act in neurodegeneration by using human neural organoids -- also known as 'mini-brain' models -- from patients with frontotemporal lobar degeneration ...

In animal models, NU-9 was found to show promise in treating Alzheimer's by reducing toxic protein buildup and brain inflammation.

GLP-1 and SGLT2 drugs — could significantly reduce the risk of developing dementia in life, a large new study has found.

C an drugs like Ozempic slow down the development of cognitive diseases, such as dementia and Alzheimer’s? According to ...

Tim-3 is an immune checkpoint molecule involved in immunity and inflammation recently linked to late-onset Alzheimer's ...

A new study has found that blood vessels in the retina may hold early clues about a person’s risk of developing dementia.

A new blood test identifies a key biomarker for Alzheimer’s disease, which may help make assessing the presence and stage of ...

Scientists at Ohio State University have made a surprising discovery about how brain cells may contribute to diseases like ...

Experimental drug NU-9 - a small molecule compound approved by the U.S. Food and Drug Administration (FDA) for clinical trials for the treatment of amyotrophic lateral sclerosis (ALS) - improves ...

Researchers have discovered a way to get anti-inflammatory medicine across the blood-brain barrier, opening the door to ...